Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
36.49%
operating margin TTM
9.78%
revenue TTM
751.48 Million
revenue per share TTM
4.41$
valuation ratios | |
|---|---|
| pe ratio | 9.61 |
| peg ratio | 0.20 |
| price to book ratio | 3.06 |
| price to sales ratio | 3.53 |
| enterprise value multiple | 29.73 |
| price fair value | 3.06 |
profitability ratios | |
|---|---|
| gross profit margin | 91.69% |
| operating profit margin | 9.78% |
| pretax profit margin | 12.96% |
| net profit margin | 36.49% |
| return on assets | 25.0% |
| return on equity | 41.9% |
| return on capital employed | 8.14% |
liquidity ratios | |
|---|---|
| current ratio | 3.83 |
| quick ratio | 3.71 |
| cash ratio | 0.64 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 142.19 |
| operating cycle | 192.68 |
| days of payables outstanding | 44.72 |
| cash conversion cycle | 147.97 |
| receivables turnover | 7.23 |
| payables turnover | 8.16 |
| inventory turnover | 2.57 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.04 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 2.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.62 |
| cash per share | 4.84 |
| operating cash flow per share | 0.65 |
| free cash flow operating cash flow ratio | 0.96 |
| cash flow coverage ratios | 2.10 |
| short term coverage ratios | 9.44 |
| capital expenditure coverage ratio | 23.42 |
Frequently Asked Questions
When was the last time ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported earnings?
ACADIA Pharmaceuticals Inc. (ACAD) published its most recent earnings results on 06-11-2025.
What is ACADIA Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)'s trailing twelve months ROE is 41.9%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ACADIA Pharmaceuticals Inc. (ACAD) currently has a ROA of 25.0%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ACAD's net profit margin stand at?
ACAD reported a profit margin of 36.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ACAD's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.83 in the most recent quarter. The quick ratio stood at 3.71, with a Debt/Eq ratio of 0.04.